Secondary arterial hypertension and endogenous hypercortisolism in general medical practice
https://doi.org/10.21886/2712-8156-2022-3-4-92-99
Abstract
Arterial hypertension (AH) is a widespread syndrome in clinical practice. In most cases, the blood pressure increase is essential (primary) in nature. Meanwhile, many clinical situations require exclusion of secondary AH due medications and other substances, renal, endocrine, cardiovascular, neurological pathology. A special place in the structure of the endocrine AH is engaged in pathology caused by excessive production of cortisol. Despite its heterogeneous origin, endogenous hype rcortisolism (EH) has a certain similarity in clinical manifestations. The article describes two clinical cases of AH in 32-year-old women with different pathogenetic variants of endogenous hypercortisolism (EH). The presented medical histories are the basis for the discussion of features of the clinical and laboratory manifestations of EH, principles of the differential diagnos is and modern approaches to treatment. The aim of this publication is to draw attention of doctors of various specialties to early detection of EH, the timely elimination of which significantly improves the quality and increases the life expectancy of patients.
About the Authors
G. G. PetrikRussian Federation
Galina G. Petrik, Dr. Sci. (Med.), Professor Chair of Therapy N1; endocrinologist Endocrinology Departmen
Krasnodar
E. D. Kosmacheva
Russian Federation
Elena D. Kosmacheva, Dr. Sci. (Med.), Professor, Head of the Department of Therapy 1; assistant to the head physician by a medical part
Krasnodar
S. V. Butaeva
Russian Federation
SvetlanaV. Butaeva, Head of the Endocrinology Department
Krasnodar
V. L. Smirnova
Russian Federation
Veronika L. Smirnova, endocrinologist Endocrinology Department
Krasnodar
A. M. Mishina
Russian Federation
Anastasia M. Mishina, endocrinologist Endocrinology Department
Krasnodar
References
1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019;40(5):475.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1
3. Steffensen C, Bak AM, Rubeck KZ, Jørgensen JO. Epidemiology of Cushing's syndrome. Neuroendocrinology. 2010;92 Suppl 1:1-5. doi: 10.1159/000314297
4. Charles L, Triscott J, Dobbs B. Secondary Hypertension: Discovering the Underlying Cause. Am Fam Physician. 2017;96(7):453-461. PMID: 29094913.
5. Белая Ж.Е., Рожинская Л.Я., Вагапова Г.Р. и соавт. Клинические рекомендации Болезнь Иценко-Кушинга: Клиника, диагностика, дифференциальная диагностика, методы лечения. Москва, 2014.
6. Nieman LK. Cushing's syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol. 2015;173(4):M33-8. doi: 10.1530/EJE-15-0464
7. Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7
8. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807-31. doi: 10.1210/jc.2015-1818
9. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015;386(9996):913-27. doi: 10.1016/S0140-6736(14)61375-1
Review
For citations:
Petrik G.G., Kosmacheva E.D., Butaeva S.V., Smirnova V.L., Mishina A.M. Secondary arterial hypertension and endogenous hypercortisolism in general medical practice. South Russian Journal of Therapeutic Practice. 2022;3(4):92-99. (In Russ.) https://doi.org/10.21886/2712-8156-2022-3-4-92-99